CI Platform
Sign in
Supernus Pharmaceuticals, Inc.SUPN.XX2NYSE NAS ASE DUS FRA LON
Current ReportFundamental Reports

North America / UNITED STATES

Report Sections1

Available for this company

Reporting UnitMillions

NYSE NAS ASE DUS FRA LON

To continue to view the full report

Buy this company's report, or subscribe to a plan.

Already bought this report? Sign in and download it from Order History on your account page; purchased reports are available for 7 days.

Buy ReportSubscribe PlansAlready a member? Sign in

Company Overview

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryPharmaceutical Preparations
CountryUNITED STATES
Employees778
Reporting UnitMillions
Primary ExchangeNYSE NAS ASE DUS FRA LON
Instrument TypeEquity
Websitehttp://www.supernus.com
Wright IDC840FMB9K

Key Metrics

Current price$28.15
Market cap$1.64 B
P/E ration/a
52-week perf.-49.5%
Common shares58.2 M
Closely held3.1 M
Share typeCommon
Quality ratingBAD0
Dividend yield0.00%

Recent stock performance

1 Week-32.9%
4 Week-33.6%
13 Week-38.8%

Officers

Non Executive ChairmanCharles W. Newhall III
President, Chief Executive & SecretaryJack A. Khattar
Senior Vice President & Chief Financial OfficerTimothy C. Dec

Address

9715 Key West Avenue

ROCKVILLE, MD

UNITED STATES

20850

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.